Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells

Published:2021-12 Issue:12 Volume:39 Page:1610-1622.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Xue Gang,Zheng Ningbo,Fang Jing,Jin Guangxu,Li Xiaoyin,Dotti Gianpietro,Yi Qing,Lu Yong

Funder

Elsa U. Pardee Foundation

Cancer Prevention and Research Institute of Texas

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference66 articles.

1. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor;Adachi;Nat. Biotechnol.,2018

2. The dark side of cyclophosphamide: cyclophosphamide-mediated ablation of regulatory T cells;Becker;J. Invest. Dermatol.,2013

3. Tumour heterogeneity in the clinic;Bedard;Nature,2013

4. TCRs used in cancer gene therapy cross-react with mart-1/melan-a tumor antigens via distinct mechanisms;Borbulevych;J. Immunol.,2011

5. Regression of glioblastoma after chimeric antigen receptor T-cell therapy;Brown;N. Engl. J. Med.,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling;Cellular & Molecular Immunology;2024-08-26

2. Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting;Human Cell;2024-06-15

3. Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer;Experimental Hematology & Oncology;2024-05-17

4. Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers;Cancer Drug Resistance;2024-05-13

5. Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy;Cancer Cell;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3